Huber Research Resources, Inc.

Secure, small-batch formulation, testing, and storage solutions for researchers and sponsors working with both non-controlled and controlled compounds, with future DEA-compliant capabilities in development.

What We Do

Huber Research Resources provides secure, small-batch formulation, analytical testing, and storage services for research compounds. We specialize in helping researchers, startups, and sponsors run precise, customizable projects that aren’t practical for large-scale manufacturers. Operating from a collaborative lab space, we support non-controlled substances today and are actively building toward DEA Schedule I–compliant capabilities for the future. Our approach offers clients faster turnaround times, tailored project design, and the flexibility to innovate without the barriers of high-volume production requirements.

• Download Capabilities Sheet

Who We Serve

We partner with research teams, biotech startups, and sponsors who need agile, small-batch solutions. Whether you’re testing a new formulation, validating stability, or exploring novel delivery methods, we provide the precision, flexibility, and turnaround speed that large-scale manufacturers can’t match. Today, we work with non-controlled substances and preclinical materials, while building toward expanded capabilities in DEA Schedule I research compounds.

Why HRR?

Huber Research Resources was built to fill the gap between early-stage research and large-scale manufacturing. Most CROs and CDMOs focus on high-volume, standardized production—leaving researchers, startups, and sponsors without options for custom, small-batch work. HRR delivers secure, precise, and flexible formulation, testing, and storage solutions tailored to your project’s unique needs.As a woman- and veteran-owned company, we bring discipline, adaptability, and a commitment to operational excellence. We understand the regulatory landscape, offer personalized scientific collaboration, and can pivot quickly as your research evolves. Whether you need rapid prototyping for a novel compound or long-term stability testing, HRR is your agile partner from concept to scale-up.

Execution Services

Secure, Compliant Infrastructure for Specialized Compound HandlingHuber Research Resources (HRR) provides the operational support researchers and sponsors need for safe, precise, and compliant early-stage development—whether working with regulated or non-regulated compounds.Our small-batch, high-control approach ensures your materials are handled, stored, and prepared to the highest quality and documentation standards, supporting both immediate research needs and smooth scale-up.Core capabilities include:Secure storage and controlled-environment handlingClimate-controlled stability and shelf-life testingSmall-batch preparation and verification for preclinical studiesInventory management and sample trackingTechnical documentation and chain-of-custody supportThese services are ideal for innovators who need precision, flexibility, and speed—without the overhead or long lead times of large-scale operations. As we expand into DEA-licensed operations, HRR will also offer full Schedule I compound capabilities.

Development Services

Custom Formulation and Method Development for Specialized CompoundsHuber Research Resources (HRR) delivers small-batch formulation and method development services to support innovation in pharmaceutical research—including psychedelic and other regulated or non-regulated compounds. We work closely with clients to design, refine, and document processes that align with both scientific objectives and regulatory best practices.Core capabilities include:Prototype dosage form development (including lyophilized and solid oral formulations)Analytical method development and validation planningFormulation optimization and feasibility studiesSupport for preclinical trial preparation and process documentationBatch record creation and early-stage scale-up consultationOur services are tailored for biotech startups, academic labs, and clinical trial sponsors seeking flexible, precise, and compliant R&D support—without the cost or lead times of large-scale manufacturing. As we move toward DEA licensure, these capabilities will extend to Schedule I psychedelic compounds.

Meet the Founder

Dayna Huber, MS | Founder

Dayna Huber is a pharmaceutical scientist, engineer, and U.S. Air Force veteran with a multidisciplinary background in regulatory compliance, process engineering, and psychoactive drug development. She holds a Master of Science in Pharmaceutical Sciences from the University of Wisconsin–Madison, with a focus on psychoactive pharmaceutical investigation.Before launching HRR, Dayna worked in both industrial engineering and cannabinoid research, leading technical projects in GMP environments and managing plant-scale system revamps. She founded Huber Research Resources to bridge the gap between psychedelic innovation and the infrastructure required for safe, compliant development.Driven by a deep commitment to scientific rigor, ethical access, and regulatory transparency, Dayna leads HRR with the belief that high-integrity research environments are the foundation of future psychedelic medicines.

Contact / Consultation Form

Let’s TalkHave a project or question? Reach out below — we typically respond within one business day.